Literature DB >> 3764356

Thought, language, and communication in schizophrenia: diagnosis and prognosis.

N C Andreasen, W M Grove.   

Abstract

Using the Scale for the Assessment of Thought, Language, and Communication (TLC), we examined the frequency of "thought disorder" in 94 normal volunteers and 100 psychiatric patients (25 each suffering from manic disorder, schizoaffective disorder, schizophrenic disorder, disorganized type, and schizophrenic disorder, paranoid type). We observed the manics to have a substantial amount of thought disorder and the normals to have a modest amount, suggesting that thought disorder is probably not pathognomonic of schizophrenia. The patients with affective illness did, however, show a somewhat different pattern of abnormality. In particular, patients with affective psychosis have more prominent positive thought disorder, while the schizophrenic patients tend to have more negative thought disorder. Evaluation of the patients 6 months later indicated that most types of thought disorder remit in the manics, while they persist in the schizophrenics; patients with schizoaffective disorder also tend to improve substantially. The strongest predictor of outcome was the presence of negative thought disorder.

Entities:  

Mesh:

Year:  1986        PMID: 3764356     DOI: 10.1093/schbul/12.3.348

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  57 in total

Review 1.  Semantics and N400: insights for schizophrenia.

Authors:  Namita Kumar; J Bruno Debruille
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

2.  Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.

Authors:  Cynthia B Solot; Tyler M Moore; Terrence Blaine Crowley; Marsha Gerdes; Edward Moss; Daniel E McGinn; Beverly S Emanuel; Elaine H Zackai; Sean Gallagher; Monica E Calkins; Kosha Ruparel; Ruben C Gur; Donna M McDonald-McGinn; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-07-27       Impact factor: 3.568

3.  The Centroid Cannot Hold: Comparing Sequential and Global Estimates of Coherence as Indicators of Formal Thought Disorder.

Authors:  Weizhe Xu; Jake Portanova; Ayesha Chander; Dror Ben-Zeev; Trevor Cohen
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

Review 4.  Can RDoC Help Find Order in Thought Disorder?

Authors:  Alex S Cohen; Thanh P Le; Taylor L Fedechko; Brita Elvevåg
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

Review 5.  Language as a biomarker for psychosis: A natural language processing approach.

Authors:  Cheryl M Corcoran; Vijay A Mittal; Carrie E Bearden; Raquel E Gur; Kasia Hitczenko; Zarina Bilgrami; Aleksandar Savic; Guillermo A Cecchi; Phillip Wolff
Journal:  Schizophr Res       Date:  2020-06-01       Impact factor: 4.939

Review 6.  The Epidemiology and Associated Phenomenology of Formal Thought Disorder: A Systematic Review.

Authors:  Eric Roche; Lisa Creed; Donagh MacMahon; Daria Brennan; Mary Clarke
Journal:  Schizophr Bull       Date:  2014-09-01       Impact factor: 9.306

7.  Building coherence: A framework for exploring the breakdown of links across clause boundaries in schizophrenia.

Authors:  Tali Ditman; Gina R Kuperberg
Journal:  J Neurolinguistics       Date:  2010-05-01       Impact factor: 1.710

8.  Prediction of psychosis across protocols and risk cohorts using automated language analysis.

Authors:  Cheryl M Corcoran; Facundo Carrillo; Diego Fernández-Slezak; Gillinder Bedi; Casimir Klim; Daniel C Javitt; Carrie E Bearden; Guillermo A Cecchi
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

9.  Disordered discourse in schizophrenia described by the Structure Building Framework.

Authors:  Morton Ann Gernsbacher; Kathleen A Tallent; Caroline M Bolliger
Journal:  Discourse Stud       Date:  1999-08

10.  Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory.

Authors:  Rebekah A E Honey; Danielle C Turner; Garry D Honey; Sam R Sharar; D Kumaran; E Pomarol-Clotet; P McKenna; B J Sahakian; T W Robbins; P C Fletcher
Journal:  Neuropsychopharmacology       Date:  2003-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.